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Abstract 
Introduction: Non-healing wounds can pose a medical challenge as in the case of vasculopathic venostasis resulting 
in a surgical ulcer. When traditional approaches to wound care fail, an amniotic patch (a dehydrated tissue allograft 
derived from human amnion) can function as a biologic scaffold to facilitate and enhance tissue regeneration and 
rehabilitation.
Background: Amniotic AlphaPatches contain concentrated molecules of PGE2, WNT4, and GDF-11 which have 
angiogenic, trophic, and anti-inflammatory effects on tissues that may be useful in enhancing wound healing.
Aim—case report: We present a case of a severe non-healing surgical wound in a 78-year-old male 17 days post 
right total knee arthroplasty. The full-thickness wound exhibited a mobile flap, measured 4 cm long × 3 cm wide, and 
showed undermining down to patellar tissue. We treated the wound conservatively for 6 weeks with no evidence of 
wound healing. Upon failure of the conservative treatment, two amniotic AlphaPatch (Amniotic Therapies, Dallas, TX, 
USA) were applied to the wound, and the wound healed completely in 10 weeks.
Methods: In the OR, the wound was irrigated with three liters of double antibiotic solution under pulse lavage. Two 
dry amniotic AlphaPatch (4 cm × 4 cm) were placed over the wound with Acticoat applied on top.
Results: At the two-week follow-up visit (following the incision and drainage of the wound dehiscence and applica-
tion of the amniotic AlphaPatch), a central scab had formed centrally in the wound dehiscence area. At the four-week 
follow-up visit, the wound dehiscence area had completely scabbed over with no open areas left. At the eight-week 
follow-up visit, the scab had just fallen off, and the wound was healing well with immature skin representing the size 
of a penny. At the ten-week follow-up visit, the wound was completely healed.
Discussion/conclusion: Sterile, dehydrated amniotic tissue AlphaPatches (containing trophic factors known to 
enhance wound healing) have proven effective in completely healing an otherwise non-healing wound in a 78-year-
old male who failed six weeks of conservative wound care treatment.
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Background
Wound healing is a complex process whereby multiple 
cell types, growth factors, and extra-cellular proteins 
interact to repair a disruption in the dermal and epider-
mal layers of the skin. In some cases, the mechanism 
behind said repair fails to restore the integrity of the 
injured tissue in a timely manner, delaying the progres-
sion of inflammatory, proliferative, and remodeling 
phases of healing [1]. The resulting chronic, non-healing 
wound is vulnerable to infection, may cause pain, reduce 
quality of life, and become a burden on the healthcare 
system [2]. Non-healing wounds, frequently seen in 
older patients [3], are associated with certain condi-
tions such as diabetes, obesity, and rheumatoid arthritis, 
but may also occur following acute trauma or surgical 
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intervention [4, 5]. It is estimated that 1–2% of patients in 
developed countries will experience non-healing wounds 
in their lifetime [6], and certain types of chronic wounds 
are estimated to account for billions of dollars of treat-
ment costs in the United States [3].
An adequate progression of wound healing [1, 7, 8] 
begins with the secretion of growth factors such as 
Transforming Growth Factor beta (TGF-β) [9], as well 
as Fibroblast (FGF), Endothelial (EGF), Platelet Derived 
(PDGF) and Vascular Endothelial (VEGF) Growth Fac-
tors [10]. Neutrophils attracted by PDGF signals clear 
excess bacteria at the site with the aid of monocytes—
later transformed to macrophages. Macrophages regu-
late the production of TGF-β, which in turn stimulates 
migration and proliferation of fibroblasts as well as epi-
thelialization [11]. Extracellular matrix and granulation 
tissue begin forming as fibroblasts secrete fibronectin 
and collagen precursors concurrently with VEGF-stim-
ulated angiogenesis which carries oxygen and nutrients 
to the injured site [12]. Finally, the collagen structure in 
the wound area matures and reassembles into a tighter 
structure with greater tensile strength. An interruption 
or delay at any stage of this complex process results in a 
non-healing wound [2, 13, 14].
Treatments for non-healing wounds include compres-
sion therapy, negative pressure wound devices [15], skin 
grafts [16, 17] and tissue bioengineering [18–20], as well 
as cell therapy [21] particularly using mesenchymal stem 
cells (MSC). These cells, known to enhance wound heal-
ing, have been broadly studied in clinical trials. Contrary 
to the early paradigm of cell replacement and differen-
tiation as a therapeutic mechanism of action, evidence is 
mounting that the secretions of the MSC are responsible 
for their therapeutic effects [22]. These secretions include 
molecules and extracellular vesicles that yield both local 
and distant effects. The most important factors present 
in a conditioned medium of MSC can also be considered 
protagonists of MSC physiological effects including HGF, 
TGF-b, VEGF, TSG-6, PGE2 and galectins 1, and 9 [22]. 
It is important to note that fresh amniotic membranes 
contain live MSCs while dehydrated amniotic mem-
branes do not. Rather, dehydrated amniotic membranes 
(as in the case of the AlphaPatch) function as a biologic 
scaffold to facilitate and enhance tissue regeneration and 
rehabilitation by way of the said molecules in addition to 
PGE2, WNT4, and GDF-11 [22].
Case report
A 78-year-old male with history of prostate cancer and 
COPD, with a 40-pack-year history of smoking presented 
for a follow-up visit in the clinic 17 days status post right 
total knee arthroplasty. During this visit, dermal sta-
ples were removed from the surgical incision. The mid 
portion of the patient’s incision showed some wound 
dehiscence, representing the same location in which 
the patient reported a previous sebaceous cyst. Cleocin 
300  mg qid was prescribed as antibiotic prophylaxis 
while Talwin 1-q4prn was prescribed for pain control. 
The dehisced area was thoroughly cleaned with alcohol 
and triple antibiotic while the remainder of the wound 
was Steri-Stripped.
One week later, the patient presented to the clinic for 
follow-up of the wound dehiscence. Upon physical exam-
ination, the wound appeared macerated and white with 
initial signs of necrosis. The wound was cleaned with 
alcohol and compressed with Ace bandage. The patient 
continued to take Cleocin antibiotic regimen.
Eleven days later (35  days post surgery), the patient 
returned to the clinic to recheck the wound. The wound 
showed slow healing with no significant drainage. To 
expedite the healing process, three Monocryl sutures 
were used to close the wound.
One week later (or 42  days post surgery), the patient 
returned to the clinic reporting that the three sutures 
expelled while he flexed his knee during physical therapy. 
The non-healing wound displayed a sympathetic effu-
sion consistent with vasculopathic venostasis resulting 
in a surgical ulcer. The wound, however, was not ery-
thematous, hot, or tender to palpation. The patient was 
scheduled the following day in the OR for drainage of 
joint effusion with gram stain, knee wound irrigation 
with pulse lavage, and application of amniotic dry patch 
to wound.
Procedure
The right lower extremity was sterilely prepped and 
draped in the usual fashion, roughly 2 months status post 
total knee arthroplasty. The joint effusion was drained, 
and 65  cc of bloody synovial fluid was removed from 
the patient’s right knee. STAT gram stain of the aspirate 
revealed negative results. The wound was then irrigated 
with three liters of double antibiotic solution under pulse 
lavage. Two (4  cm ×  4  cm) dry amniotic AlphaPatches 
(Amniotic Therapies, Dallas, TX, USA) were placed over 
the wound with Acticoat applied on top. Then 4  ×  4’s, 
Webril, and Ace wrap were applied to the knee. The 
patient tolerated the procedure well and was transferred 
to the recovery room in stable condition (Fig. 1).
Results
At the two-week follow-up visit (following the incision 
and drainage of the wound dehiscence and application of 
the amniotic AlphaPatch), a central scab had formed in 
the middle of the wound dehiscence area (Fig. 2). At the 
four-week follow-up visit, the wound dehiscence area had 
completely scabbed over with no open areas left (Fig. 3). 
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At the eight-week follow-up visit, the scab had just fallen 
off, and the wound was healing well with immature skin 
representing the size of a penny (Fig. 4). At the ten-week 
follow-up visit, the wound had completely healed (Fig. 5), 
patient demonstrated full knee ROM (120° of flexion and 
180° of extension), and patient was released from ortho-
paedic care.
Discussion
Although the 78-year-old patient demonstrated excellent 
results in ROM and overall decreased pain levels follow-
ing right total knee arthroplasty, the non-healing status 
of the surgical wound at even 42 days status post surgery 
posed great concern. The vasculopathic venostasis result-
ing in a surgical ulcer left very little option than to per-
form dehiscence wound irrigation with pulse lavage and 
to apply dry amniotic AlphaPatch to the wound.
The amniotic AlphaPatch, a dehydrated amniotic tis-
sue allograft, contains the molecules PGE2, WNT4, and 
GDF-11. Mesenchymal stem cells (MSCs) secrete PGE2, 
or Prostaglandin E2, in response to injury. This molecule 
inhibits fibrosis by way of limiting fibroblast proliferation, 
migration, collagen secretion, and transforming growth 
factor (TGF)-induced myofibroblast that can spur fibro-
blast proliferation [23]. PGE2 also enhances the wound 
healing process and angiogenesis [24]. WNT4, a protein, 
drives wound healing by way of wound re-epithelializa-
tion and cell proliferation [25]. The creation of new tissue 
Fig. 1 Pre-lavage. Fig. 2 Two weeks post-lavage and amniotic Alpha Patch application.
Fig. 3 Four weeks post-lavage and amniotic Alpha Patch application.
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materializes by multiple methods including new blood 
vessel formation, a critical element for normal wound 
healing [26]. GDF-11, or growth/differentiation factor 11, 
has been identified as one of the key molecules propelling 
the regeneration of skeletal muscle, cardiac muscle, and 
nervous tissue in aged mice [27].
The two dry amniotic patches applied on the patient’s 
wound substantially accelerated the wound healing pro-
cess. The dehisced surgical wound that showed no sign of 
healing even after 42 days post total knee replacement sur-
gery, demonstrated a central scab formation in the middle 
of the wound dehiscence area only after 2 weeks of amni-
otic patch application. After eight more weeks, the wound 
was completely healed and the patient was released from 
orthopaedic care to assume high levels of physical activ-
ity and activities of daily living. Although more studies are 
warranted to further substantiate the therapeutic benefits 
of this treatment, we suggest unreservedly that dehydrated 
tissue allograft patches derived from human amnion 
embody a viable and more effective alternative to current 
traditional means of wound care management.
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